We aimed to describe the mortality burden and macroeconomic effects of head and neck cancer as well as delineate the role of surgical workforce in improving head and neck cancer outcomes.
Study Design
Statistical and economic analysis.
Setting
Research group.
Subjects and Methods
We conducted a statistical analysis on data from the World Development Indicators and the 2016 Global Burden of Disease study to describe the relationship between surgical workforce and global head and neck cancer mortality-to-incidence ratios. A value of lost output model was used to project the global macroeconomic effects of head and neck cancer.
Results
Significant differences in mortality-to-incidence ratios existed between Global Burden of Disease study superregions. An increase of surgical, anesthetic, and obstetric provider density by 10% significantly correlated with a reduction of 0.76% in mortality-to-incidence ratio (P < .0001; adjusted R2 = 0.84). There will be a projected global cumulative loss of $535 billion US dollars (USD) in economic output due to head and neck cancer between 2018 and 2030. Southeast Asia, East Asia, and Oceania will suffer the greatest gross domestic product (GDP) losses at $180 billion USD, and South Asia will lose $133 billion USD.
Conclusion
The mortality burden of head and neck cancer is increasing and disproportionately affects those in low- and middle-income countries and regions with limited surgical workforces. This imbalance results in large and growing economic losses in countries that already face significant resource constraints. Urgent investment in the surgical workforce is necessary to ensure access to timely surgical services and reverse these negative trends.
VosTAbajobirAAAbateKH, et al. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017;390:1211-1259.
AlkireBCBergmarkRWChambersK, et al. Head and neck cancer in South Asia: Macroeconomic consequences and the role of the head and neck surgeon. Head Neck. 2016;38:1242-1247.
4.
Financial catastrophe, treatment discontinuation and death associated with surgically operable cancer in South-East Asia: Results from the ACTION Study. Surgery. 2015;157:971-982.
5.
FaganJJZafereoMAswaniJNettervilleJLKochW. Head and neck surgical subspecialty training in Africa: sustainable models to improve cancer care in developing countries. Head Neck. 2017;39:605-611.
6.
FaganJJAswaniJOtitiJ, et al. Educational workshops with graduates of the University of Cape Town Karl Storz Head and Neck Surgery Fellowship Program: a model for collaboration in outreach to developing countries. SpringerPlus. 2016;5:1652.
7.
WilsonBEJacobSYapMLFerlayJBrayFBartonMB. Estimates of global chemotherapy demands and corresponding physician workforce requirements for 2018 and 2040: a population-based study. Lancet Oncol. 2019;20:769-780.
8.
AtunRJaffrayDABartonMB, et al. Expanding global access to radiotherapy. Lancet Oncol. 2015;16:1153-1186.
9.
FaganJJOtitiJAswaniJ, et al. African head and neck fellowships: a model for a sustainable impact on head and neck cancer care in developing countries. Head Neck. 2019;41:1824-1829.
10.
MearaJGLeatherAJMHaganderL, et al. Global Surgery 2030: evidence and solutions for achieving health, welfare, and economic development. Lancet. 2015;386:569-624.
RoaLJumbamDTMakasaEMearaJG. Global surgery and the sustainable development goals. BJS. 2019;106:e44-e52.
13.
Global Burden of Disease Collaborative Network. Global Burden of Disease Study 2016 (GBD 2016) Causes of Death and Nonfatal Causes Mapped to ICD Codes. Seattle, WA: Institute for Health Metrics and Evaluation (IHME); 2017. http://ghdx.healthdata.org/record/ihme-data/gbd-2016-cause-icd-code-mappings. Accessed February 14, 2019.
Asadzadeh VostakolaeiFKarim-KosHEJanssen-HeijnenMLGVisserOVerbeekALMKiemeneyLALM. The validity of the mortality to incidence ratio as a proxy for site-specific cancer survival. Eur J Public Health. 2011;21:573-577.
17.
ChoiELeeSNhungBC, et al. Cancer mortality-to-incidence ratio as an indicator of cancer management outcomes in Organization for Economic Cooperation and Development countries. Epidemiol Health. 2017;39:e2017006.
18.
SunkaraVHébertJR. The colorectal cancer mortality-to-incidence ratio as an indicator of global cancer screening and care. Cancer. 2015;121:1563-1569.
19.
AlbuttKPunchakMKayimaPNamanyaDBShrimeMG. Operative volume and surgical case distribution in Uganda’s public sector: a stratified randomized evaluation of nationwide surgical capacity. BMC Health Serv Res. 2019;19:104.
AlkireBCPetersAWShrimeMGMearaJG. The economic consequences of mortality amenable to high-quality health care in low- and middle-income countries. Health Aff (Millwood). 2018;37:988-996.
22.
RudolfsonNDewanMCParkKBShrimeMGMearaJGAlkireBC. The economic consequences of neurosurgical disease in low- and middle-income countries. J Neurosurg. 2018;130:1149-1156.
23.
AlkireBCShrimeMGDareAJVincentJRMearaJG. Global economic consequences of selected surgical diseases: a modelling study. Lancet Glob Health. 2015;3:S21-S27.
24.
BloomDECafiero-FonsecaETMcGovernME, et al. The macroeconomic impact of non-communicable diseases in China and India: estimates, projections, and comparisons. J Econ Ageing. 2014;4:100-111.
AbegundeDOMathersCDAdamTOrtegonMStrongK. The burden and costs of chronic diseases in low-income and middle-income countries. Lancet. 2007;370:1929-1938.
27.
CobbCWDouglasPH. A theory of production. Am Econ Rev. 1928;18:139-165.
28.
ForemanKJMarquezNDolgertA, et al. Forecasting life expectancy, years of life lost, and all-cause and cause-specific mortality for 250 causes of death: reference and alternative scenarios for 2016-40 for 195 countries and territories. Lancet. 2018;392:2052-2090.
29.
Global Burden of Disease Health Financing Collaborator Network. Future and potential spending on health 2015-40: development assistance for health, and government, prepaid private, and out-of-pocket health spending in 184 countries. Lancet. 2017;389:2005-2030.
30.
ILOSTAT—the world’s leading source of labour statistics. http://www.ilo.org/ilostat. Accessed May 27, 2019.
MurrayCJLEzzatiMFlaxmanAD, et al. GBD 2010: design, definitions, and metrics. Lancet. 2012;380:2063-2066.
33.
SaundersJERankinZNoonanKY. Otolaryngology and the global burden of disease. Otolaryngol Clin North Am. 2018;51:515-534.
34.
GuptaBJohnsonNWKumarN. Global epidemiology of head and neck cancers: a continuing challenge. Oncology. 2016;91:13-23.
35.
WarnakulasuriyaS. Global epidemiology of oral and oropharyngeal cancer. Oral Oncol. 2009;45:309-316.
36.
ChaturvediPSinghaviHMalikANairD. Outcome of head and neck squamous cell cancers in low-resource settings: challenges and opportunities. Otolaryngol Clin North Am. 2018;51:619-629.
37.
ChaturvediAKAndersonWFLortet-TieulentJ, et al. Worldwide trends in incidence rates for oral cavity and oropharyngeal cancers. J Clin Oncol. 2013;31:4550-4559.
38.
ShieldKDFerlayJJemalA, et al. The global incidence of lip, oral cavity, and pharyngeal cancers by subsite in 2012. CA Cancer J Clin. 2017;67:51-64.
39.
HusseinAAHelderMNde VisscherJG, et al. Global incidence of oral and oropharynx cancer in patients younger than 45 years versus older patients: a systematic review. Eur J Cancer. 2017;82:115-127.
40.
FullerATCorleyJTranTM, et al. Prevalence of surgically untreated face, head, and neck conditions in Uganda: a cross-sectional nationwide household survey. World Neurosurg. 2018;110:e747-e754.
41.
Van BurenNCGroenRSKushnerAL, et al. Untreated head and neck surgical disease in Sierra Leone: a cross-sectional, countrywide survey. Otolaryngol Neck Surg. 2014;151(4):638-645.
42.
DanielsKMRieselJNMearaJG. The scale-up of the surgical workforce. Lancet. 2015;385:S41.
43.
VerguetSAlkireBCBicklerSW, et al. Timing and cost of scaling up surgical services in low-income and middle-income countries from 2012 to 2030: a modelling study. Lancet Glob Health. 2015;3:S28-S37.
44.
ChisholmDStancioleAEEdejerTTTEvansDB. Economic impact of disease and injury: counting what matters. BMJ. 2010;340:c924.
SondermanKACitronIMearaJG. National surgical, obstetric, and anesthesia planning in the context of global surgery: the way forward. JAMA Surg. 2018;153:959-960.
World Federation of Societies of Anaesthesiologists. https://www.wfsahq.org/. Accessed August 17, 2019.
50.
Centers for Disease Control and Prevention (CDC). Annual smoking-attributable mortality, years of potential life lost, and productivity losses—United States, 1997-2001. MMWR Morb Mortal Wkly Rep. 2005;54:625-628.
51.
KlussmannJPSchädlichPKChenXRémyV. Annual cost of hospitalization, inpatient rehabilitation, and sick leave for head and neck cancers in Germany. Clin Outcomes Res CEOR. 2013;5:203-213.
52.
RezapourAJahangiriROlyaeemaneshAKalaghchiBNouhiMNahvijouA. The economic burden of oral cancer in Iran. PLoS ONE. 2018;13:e0203059.
53.
HolmerHBekeleAHaganderL, et al. Evaluating the collection, comparability and findings of six global surgery indicators. BJS. 2019;106:e138-e150.
54.
FitzmauriceCAkinyemijuTFAl LamiFH, et al. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 29 cancer groups, 1990 to 2016. JAMA Oncol. 2018;4:1553-1568.
55.
NaghaviMAbajobirAAAbbafatiC, et al. Global, regional, and national age-sex specific mortality for 264 causes of death, 1980-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017;390:1151-1210.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
